AB
KPTI icon

Amalgamated Bank’s Karyopharm Therapeutics KPTI Stock Holding History

Amalgamated Bank’s Portfolio KPTI Stock Details KPTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-165
Closed -$4K – 3065
2024
Q1 		$4K Sell
165
-815
-83% -$14.3K ﹤0.01% 2782
2023
Q4 		$13K Sell
980
-49
-5% -$660 ﹤0.01% 2808
2023
Q3 		$21K Hold
1,029
– – ﹤0.01% 2638
2023
Q2 		$28K Buy
1,029
+324
+46% +$14K ﹤0.01% 2571
2023
Q1 		$41K Sell
705
-96
-12% -$4.74K ﹤0.01% 2382
2022
Q4 		$41K Hold
801
– – ﹤0.01% 2511
2022
Q3 		$66K Buy
801
+13
+2% +$971 ﹤0.01% 2339
2022
Q2 		$53K Buy
788
+7
+0.9% +$642 ﹤0.01% 2448
2022
Q1 		$86K Sell
781
-66
-8% -$8.23K ﹤0.01% 2251
2021
Q4 		$82K Sell
847
-24
-3% -$2.39K ﹤0.01% 2082
2021
Q3 		$76K Sell
871
-35
-4% -$3.63K ﹤0.01% 2105
2021
Q2 		$140K Buy
906
+234
+35% +$34K ﹤0.01% 2076
2021
Q1 		$106K Sell
672
-59
-8% -$12.4K ﹤0.01% 1550
2020
Q4 		$170K Buy
731
+4
+0.6% +$927 0.01% 1478
2020
Q3 		$159K Sell
727
-22
-3% -$5.38K 0.01% 1348
2020
Q2 		$213K Buy
749
+44
+6% +$13K 0.01% 1266
2020
Q1 		$203K Sell
705
-20
-3% -$5.52K 0.01% 1357
2019
Q4 		$208K Buy
725
+41
+6% +$8.89K ﹤0.01% 1618
2019
Q3 		$99K Sell
684
-5
-0.7% -$678 ﹤0.01% 1659
2019
Q2 		$62K Buy
+689
New +$55.3K ﹤0.01% 1729

Other funds holding KPTI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Amalgamated Bank's KPTI Position: Q2 2024 in Review

Amalgamated Bank sold out of Karyopharm Therapeutics (KPTI) in Q2 2024, closing a stake of 165 shares — an estimated $4K sold.

Amalgamated Bank first reported a position in KPTI in Q2 2019 and held it in 20 quarters. The position peaked at $213K in Q2 2020. 114 funds tracked by Wall St. Rank hold KPTI as of Q2 2024.

  • Amalgamated Bank reported no remaining Karyopharm Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Amalgamated Bank sold 165 Karyopharm Therapeutics shares in Q2 2024, an estimated $4K.
  • Amalgamated Bank first reported a position in Karyopharm Therapeutics in Q2 2019 and held it in 20 quarters.
  • Amalgamated Bank's Karyopharm Therapeutics position peaked at $213K in Q2 2020.
  • 114 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q2 2024.

Based on Amalgamated Bank's 13F filing for Q2 2024, filed 12 Aug 2024.